MENU
CSCI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

COSCIENS Biopharma (CSCI) Ownership - Who owns COSCIENS Biopharma?

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.4M
P/E Ratio
N/A
Total Cash
13.76M
Projected Growth
N/A
Total Debt
2.23M
Revenue
9.03M
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
4.37
Total Debt/Equity
N/A
Revenue/Share
3.11 USD as % of share price

Fundamentals

CSCI
Capitalization
10.4M
P/E Ratio
N/A
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
13.8M
Total Cash/Share
4.37
Total Debt
2.23M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.11%
Revenue
9.03M
ROE
N/A
Book Value
10.1M
P/B Ratio
1.04
Cash Flow
N/A
Earnings
-6.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
22.5M
Current Ratio
2.88
Current Revenue Per Employee
37500.00
Dividends Per Share - Security
N/A
EBITDA
-15.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
29.53
Revenue To Assets
-66.39
Shares Held By Institutions
34.8K
Shares Outstanding - Current
3.15M
Total Liabilities
21M
Total Volume MTD
N/A
Value
N/A
Gain YTD
20.578
View a ticker or compare two or three
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A